Already outperformers in FY24, leading listed players may witness further uptick, say analysts
The stock of pharma major Lupin is up 14 per cent over the last eight trading sessions and is trading at Rs 1,406 a share. The gains are on expectations that margins will improve
Yellow metal to maintain its impressive run in 2024 on the back of triggers such as the moderation in US economic growth, expectation of rate cuts this year and continued buying from central banks
The concern for most brokerages is valuations. Given the sharp rally in midcap and smallcap indices, investors are better off sticking with largecaps in 2024
The slowdown in consumption was on account of higher food inflation that had impacted the home and personal care segment
Despite these cuts, the brokerage maintains a buy rating on the stock
With inventory levels still declining, and pricing strong, developers are pushing for new launches in 3Q to capitalize on the demand, says Jefferies Research
The start of a new year is also a good time to make bets on stocks that have been laggards and could potentially see a turnaround in their fortunes next year
Tread with caution: Any discount/price cut in the replacement market could offset margin gains
The world's largest alternative asset manager, through its investment companies, sold a 23.59 per cent stake in the company, leaving the Embassy group as the sole sponsor of the REIT
The recent trigger has been the launch of its Kolshet project (Thane) called Forestville in November
Indian QSR chain expands international presence by buying firm that runs KFC outlets in Thailand
The double-digit growth of the company is better than FMCG peers
But lower commodity prices are likely to support margins
The company posted an 8 per cent decline in revenues both over the year-ago quarter as well as on a sequential basis in the September quarter
In the medium term, brokerage firms also highlight a robust pipeline prospect for the PSU
One positive from PI Industries' perspective is the diversification of its revenue base into pharmaceuticals
Facing a 7% dip against a soaring Sensex, FMCG major's stock outlook raises caution, with investors eyeing volume recovery, pricing manoeuvres, and margin dynamics for cues
Commercial real estate players, especially large asset owners such as Embassy, Mindspace, Brookfield and DLF, were bearing the brunt of vacancies in SEZ space
DAC's Rs 2.23 trillion proposal approval likely to pay rich dividends to HAL